2008
PloS one, (2008).3 5 10.1371/journal.pone.0002280.
2008
Malaria journal, (2008).7 1 10.1186/1475-2875-7-38.
2008
Malaria journal, (2008).7 1 10.1186/1475-2875-7-149.
Intermittent Preventive Treatment of Malaria in Infants in an Area of High Sp Resistance in Tanzania: A Randomized Double Blind Placebo Controlled Trial of Sp, Lapdap or Mefloquine for Prevention of Malaria in Infants.
2008
The American journal of tropical medicine and hygiene, (2008).79 6
2008
PLoS medicine, (2008).5 11 10.1371/journal.pmed.0050226.
2008
PloS one, (2008).3 5 10.1371/journal.pone.0002281.
2008
Lancet, (2008).371 9614 10.1016/S0140-6736(08)60338-4.
2008
Malaria journal, (2008).7 1 10.1186/1475-2875-7-148.
Policy Implications of the Results from the Randomized Double Blind Placebo Controlled Trial of Sp, Lapdap or Mefloquine for Prevention of Malaria in Infants Study in North-Eastern Tanzania.
2008
The American journal of tropical medicine and hygiene, (2008).79 6